Trials / Completed
CompletedNCT02308098
To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product
Study Comparing Bronchodilator Efficacy of Two Dry Powder Inhalers, Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler; a Randomised, Double-blind, Double-dummy, Multicentre, Single Dose, Crossover Study in Asthmatic Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm equivalent bronchodilator efficacy of the test product compared to the reference product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh | |
| DRUG | Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh | |
| DRUG | Symbicort Turbuhaler 320/9 ug/inhalation 4 inh | |
| DRUG | Symbicort Turbuhaler 320/9 ug/inhalation 1inh | |
| DRUG | Placebo Symbicort Turbuhaler 320/9 ug/inhalation 4 inh | |
| DRUG | Placebo Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh | |
| DRUG | Placebo Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh | |
| DRUG | Placebo Symbicort Turbuhaler 320/9 ug/inhalation 1 inh |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2014-12-04
- Last updated
- 2015-06-30
Locations
1 site across 1 country: Bulgaria
Source: ClinicalTrials.gov record NCT02308098. Inclusion in this directory is not an endorsement.